Related Experiment Video
Updated: Mar 24, 2026

Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis
Published on: October 13, 2016
Dementia and Amyotrophic Lateral Sclerosis
F R Verhey1, F W Vreeling2, J Jolles1
1vakgroep neuropsychologic en psychobiologie,Rijksuniversiteit Limburg en afdeling klinische psychiatrie Academisch Ziekenhuis Maastricht.
This study presents two cases of Amyotrophic Lateral Sclerosis and dementia (ALS-D), a condition at the intersection of frontal lobe dementia and ALS. The nosological classification for this complex remains undetermined.
Area of Science:
- Neurology
- Neurodegenerative Diseases
- Cognitive Neurology
Background:
- Amyotrophic Lateral Sclerosis (ALS) is a progressive motor neuron disease.
- Dementia involves cognitive decline, often affecting frontal lobe functions.
- The co-occurrence of ALS and dementia presents diagnostic and classification challenges.
Purpose of the Study:
- To present case histories of patients with concurrent ALS and dementia (ALS-D).
- To discuss the current literature regarding the interface between non-Alzheimer frontal lobe dementia and ALS.
- To highlight the unresolved nosological classification of the ALS-D complex.
Main Methods:
- Case study methodology.
- Review of recent scientific literature on ALS and dementia.
- Clinical and pathological analysis (implied).
Main Results:
- Detailed case histories of two patients exhibiting both ALS and dementia symptoms.
- Literature review indicating ALS-D as a distinct clinical entity or interface.
- Identification of the lack of established nosological classification for ALS-D.
Conclusions:
- ALS-D represents a complex clinical presentation at the intersection of neurodegenerative conditions.
- Further research is required to establish a clear nosological framework for ALS-D.
- Understanding ALS-D is crucial for accurate diagnosis and patient management.
Related Concept Videos
Parkinson's Disease: Overview
Dementia
The progression of dementia is generally gradual....
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Cross-bridge Cycle
Alzheimer's Disease: Treatment
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...

